medica 2011 catalogue

45
2011 Israel Medical Innovation Come meet us at hall 16: G40 in

Upload: trade-gov-il

Post on 08-May-2015

2.191 views

Category:

Health & Medicine


3 download

TRANSCRIPT

Page 1: Medica 2011 catalogue

2011Israel Medical Innovation

Come meet us at hall 16: G40 in

Page 2: Medica 2011 catalogue

Israel Medical Innovation 2011

2

Page Contents

Table of Contents (By Category)

Table of Contents (By Alphabetical Order)

Company Profiles

Schedule a Meeting

3

7

12

44

Page 3: Medica 2011 catalogue

3

Table of Contents (by category) Click on Company’s name for more details

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

Category Company

Aesthetics and Dermatology Cnoga

CoolSense Medical

Erika Carmel Ltd.

TavTech

Cardiovascular and Peripheral Vascular BSP Biological Signal Processing

Cnoga

Elitar Medical

HypnoCore

Itamar Medical

Sion Biotext Medical

Diagnostics 3QBD

BSP Biological Signal Processing

Cnoga

DYN Diagnostics

Elitar Medical

HypnoCore

Itamar Medical

Medoc

Vasa Applied Technologies

Disposables and Implantable Albaad

Etview

First Care Products

Intromedix

Mizra Medical

Nava Group

Noam Urim Enterprises

OHK Medical Devices

Sion Biotext Medical

Vasa Applied Technologies

E.M.S. Beth-El Industries

Etview

First Care Products

Flight Medical

Page 4: Medica 2011 catalogue

4

Table of Contents (by category) Click on Company’s name for more details

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

Category Company

General Health Aerotel

Albaad

Cnoga

CoolSense Medical

EarlySense

Elitar Medical

Itamar Medical

Mizra Medical

Motorika

Nava Group

Noam Urim Enterprises

General Surgery Beth-El Industries

Etview

Intromedix

OHK Medical Devices

Infection Control and Infectious Diseases Albaad

Beth-El Industries

Hyginex

Mizra Medical

NanoVibronix

Noam Urim Enterprises

Sion Biotext Medical

Industrial OEM Albaad

Noam Urim Enterprises

Intensive Care Etview

Flight Medical

Vasa Applied Technologies

Laboratory Equipment DYN Diagnostics

Page 5: Medica 2011 catalogue

5

Table of Contents (by category) Click on Company’s name for more details

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

Medical and Hospital Equipment Aerotel

Beth-El Industries

CoolSense Medical

Discover Medical Devices

EarlySense

Erika Carmel Ltd.

ETView

Flight Medical

Hyginex

Intromedix

Motorika

NanoVibronix

OHK Medical Devices

Polytex Technologies

TavTech

Monitoring Cnoga

EarlySense

Elitar Medical

Hyginex

HypnoCore

Vasa Applied Technologies

Neurology and Degenerative Diseases CoolSense Medical

Itamar Medical

Medoc

Motorika

Rehabilitation Erika Carmel Ltd.

Flight Medical

Motorika

Respiratory and Pulmonary Discover Medical Devices

ETView

Flight Medical

HypnoCore

Itamar Medical

Robotics DYN Diagnostics

Motorika

Services 2P2D Solutions

Arazy Group

Category Company

Page 6: Medica 2011 catalogue

6

Table of Contents (by category) Click on Company’s name for more details

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

Telemedicine and Healthcare IT 2P2D Solutions

Elitar Medical

HypnoCore

Urology Mizra Medical

NanoVibronix

Vasa Applied Technologies

Wound and Pain Management Erika Carmel Ltd.

Medoc

NanoVibronix

Sion Biotext Medical

Category Company

Page 7: Medica 2011 catalogue

7

Table of Contents (by alphabetical order)

Page

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

15

14

13

12

16

17

18

19

Company Category

2P2D SOLUTIONS Telemedicine and Helathcare IT

Services

3QBD Diagnostics

AerotelGeneral Health

Medical and Hospital Equipment

Albaad Disposables and Implantable

General Health

Industrial OEM

Infection Control and Infectious Diseases

Arazy Group Services

Beth-El Industries Medical and Hospital Equipment

Infection Control and Infectious Diseases

E.M.S

General Surgery

BSP Biological Signal Processing Diagnostics

Cardiovascular and Peripheral Vascular

Cnoga Monitoring

Cardiovascular and Peripheral Vascular

Diagnostics

General Health

Aesthetics and Dermatology

Page 8: Medica 2011 catalogue

8

Table of Contents (by alphabetical order)

Page

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

26

25

CoolSense Medical Medical and Hospital Equipment

Aesthetics and Dermatology

General Health

Neurology and Degenerative Diseases

Discover Medical Devices Medical and Hospital Equipment

Respiratory and Pulmonary

DYN Diagnostics Diagnostics

Robotics

Laboratory Equipment

EarlySense Medical and Hospital Equipment

Monitoring

General Health

Elitar Medical Diagnostics

Monitoring

Telemedicine and Healthcare IT

Cardiovascular and Peripheral Vascular

General Health

Erika Carmel Ltd. Wound and Pain Management

Medical and Hospital Equipment

Rehabilitation

ETView Disposables and Implantable

Intensive Care

General Surgery

Respiratory and Pulmonary

E.M.S

Medical and Hospital Equipment

Company Category Therapeutic Area(s)

23

24

20

21

22

Page 9: Medica 2011 catalogue

9

Table of Contents (by alphabetical order)

Page

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

First Care Products Disposables and Implantable

E.M.S

Flight Medical Medical and Hospital Equipment

Rehabilitation

Intensive Care

Respiratory and Pulmonary

E.M.S

Hyginex Monitoring

Infection Control and Infectious Diseases

Medical and Hospital Equipment

HypnoCore Diagnostics

Medical and Hospital Equipment

Monitoring

Telemedicine and Helathcare IT

Cardiovascular and Peripheral Vascular

Respiratory and Pulmonary

Intromedix Disposables and Implantable

Medical and Hospital Equipment

General Surgery

Itamar Medical Diagnostics

Cardiovascular and Peripheral Vascular

General Health

Neurology and Degenerative Diseases

Respiratory and Pulmonary

Company Category Therapeutic Area(s)

30

31

32

27

28

29

Page 10: Medica 2011 catalogue

10

Table of Contents (by alphabetical order)

Page

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

Medoc Diagnostics

Neurology and Degenerative Diseases

Wound and Pain Management

Mizra Medical Disposables and Implantable

Urology

General Health

Infection Control and Infectious Diseases

Motorika Medical Medical and Hospital Equipment

Robotics

Rehabilitation

Neurology and Degenerative Diseases

General Health

NanoVibronix Urology

Wound and Pain Management

Infection Control and Infectious Diseases

Medical and Hospital Equipment

Nava Group Disposables and Implantable

General Health

Noam Urim Enterprises Disposables and Implantable

Industrial OEM

General Health

Infection Control and Infectious Diseases

OHK Medical Devices Medical and Hospital Equipment

General Surgery

Disposables and Implantable

Company Category Therapeutic Area(s)

39

37

38

36

35

33

34

Page 11: Medica 2011 catalogue

11

Table of Contents (by alphabetical order)

Page

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting at

Polytex Technologies Medical and Hospital Equipment

Sion Biotex Medical Disposables and Implantable

Cardiovascular and Peripheral Vascular

Wound and Pain Management

Infection Control and Infectious Diseases

TavTech Medical and Hospital Equipment

Aesthetics and Dermatology

Vasa Applied Technologies Disposables and Implantable

Monitoring

Diagnostic

Urology

Intensive Care

Company Category Therapeutic Area(s)

43

40

41

42

Page 12: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

12

Schedule a Meeting at

Category:

Telemedicine andHealthcare IT

Services

Company Status:

Complete Validation Study

www.2p2d.com2P2D SOLUTIONS

Company at a Glance2P2D Solutions Ltd. is a pioneering technology-based company developing unique solutions for various unmet needs within the healthcare, biotech and pharmaceutical industries.2P2D Solutions Ltd. has developed a breakthrough automated drug monitoring system for use in clinical drug trials that incorporates a portable, personalized medication dispensing device using proprietary 2P2D technology.

Technology and Product(s)2P2D Solutions Ltd. has developed ClinicAid, a breakthrough automated drug monitoring system that incorporates a portable medication dispensing device using proprietary 2P2D technology. The system dispenses personalized drug dosages designated for each specific patient or group of patients. After patient identification has been fully authorized, according to the designated clinical trial treatment regimen. This exclusive medication management system, for use in clinical drug trials, ensures unequaled compliance, accountability and accuracy.

The Company’s telemedicine solution provides:• Complete and real-time knowledge of the participant’s compliance and adherence to

the trial protocols.• Reduced overall duration of the clinical trial period.• Increased participant’s compliance and adherence to the given medication.• Cost effective solution for clinical trial packaging and drug accountability.

GoalObjectives: Investment, Strategic Alliances

Target businesses: CROs, Pharma companies, Hospitals

Target Countries: Worldwide

Page 13: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

13

Schedule a Meeting at

Category:

Diagnostics

www.3qbd.com3QBD

Company at a GlanceLocated in Arad, Israel, 3QBD Ltd. is an ISO certified start up medical device company. The company has developed the VGTest, is an In-Vitro Molecular Diagnostic (IVD) device based on Ion Mobility Spectrometry (IMS) which is used currently for detection of Vaginal Discharge Infections (VDI). In December 2009 3QBD Ltd. received the European CE mark for the VGTest, a device capable of detecting and provides a positive/negative indication for Bacterial Vaginosis (BV), the most prevalent women’s vaginal infection within 60 seconds. Future development plans for 3QBD include further research into the VDI field, to detect additional infections and expanding to other diseases like STD and Cancer, to offer rapid, accurate results. Further expending to other markets like food and livestock.

Technology and Product(s)IMS (Ion Mobility Spectrometry) Technology3QBD’s technology is based on the well established and scientifically proven Ion Mobility Spectrometry (IMS) technology – first used successfully to detect drugs and explosives. Today IMS is being used to detect presence and type of infection.Chemical changes in living systems, or degradation of cells after death through enzymatic and microbial processes, are accompanied by the breakdown of amino-acids and production of biogenic amines. Pathological conditions in the human body may be expressed in the formation of biogenic amines, so that elevated levels of biogenic amines may be indicative of dysfunctions. IMS is a sensitive instrumental technique for detecting volatile compounds. It is based on measuring the velocity of ions (ion mobility) drifting through a gas bath under the influence of an electric field.

The ProductThe device works by measuring biogenic amines that are present at elevated levels in infections and diseases and provides a rapid and accurate indication. In the case of the BV the result is provided within one minute. The VGTest for BV spares the physician from having to perform the Amsel Test and “whiff tests” of vaginal fluid or spend time waiting for laboratory Gram Stain results

GoalObjectives: Distribution for BV, Strategic allaincess, R&D Funding

Target businesses: Women’s Health professionals, gynecologists, obstetricians, hospitals and health clinics

Target Countries: Worldwide

Page 14: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

14

Schedule a Meeting at

Company at a GlanceAerotel is one of Israel’s longest established high tech companies, specializing in the manufacturing of communication and medical devices. Aerotel is known for being the first company in Israel to develop an interactive voice response (IVR) system as well as the portable “Hi-Pack” ECG gauge. The company has exported its products internationally to approximately 40 countries. Its large and diverse customer base includes leading multi-national corporations such as AT&T.The innovative MDwave system is a revolutionary development in the frequency therapy field which brings new hope to patients who have been unable to treat themselves by means of conventional medicine.Based on extensive experience in offering individualized personal service to patients, Aerotel has designed the MDwave to provide maximum flexibility and efficiency to meet each patient’s distinctive requirements. Aerotel experts are continually working to include the latest Frequency Medicine knowhow, in the MDwave system. This product has been developed over an eight-year period and is complaint with the following standards: FCC and CE 60601-1 and 2.

Technology and Product(s)Aerotel Ltd. has developed a breakthrough medical device, known as MDwave, which restores energy levels and treats chronic and acute conditions through the use of Frequency Medicine. Recent studies have demonstrated the positive effect of a low strength electromagnetic field in specific frequencies, on various systems of our body, demonstrating high efficacy of such treatments.MDwave is based on creating a low electromagnetic field that impacts the human cell properties under health and diseased conditions. This field delivers a safe electromagnetic energy to the human cells, which encourages them to return to proper and balanced function, and to operate in a healthy and harmonious way. This enables the immune system to improve its ability to withstand the daily battle against energy-sapping pollutants, hence increasing the body’s ability to heal itself.MDwave is a completely safe, compact and easy-to-use device for administering Frequency Medicine therapy, via an Electromagnetic field. To get started, you simply connect the MDwave to a computer and choose from an extensive list of treatments the desired routine for your patient. Once the treatment routine is set, the MDwave operates without a computer.

GoalObjectives: Searching for distributors

Target businesses: Distributors

Target Countries: Worldwide

Category:

General Health

Medical andHospital Equipment

Company Status:

Clinical Trials

www.aerotel.co.ilAerotel

Page 15: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

15

Schedule a Meeting at

Company at a GlanceAlbaad is one of the three leading producers of wipes worldwide. As a fully integrated converter with production facilities in Germany, US and Israel, global R&D, regulatory suport and engineering teams, Albaad is a preferred contract manufacturing partner for renowned multinationals and retailers.We don’t just make wet wipes; we make it our business to know everything there is to know about them, constantly studying customer needs, market trends and technological innovations.

Technology and Product(s)Albaad has registered a range of products intended for professional and consumer healthcare use. Our disinfection products are registered as medical device class 2a (FDA and EPA where applicable). Production is also ISO 13485 certified. The range includes several surface and medical device disinfectants, hand hygiene, patient care and bathing kits, adult incontinence wipes and several consumer solutions including natural fever relief, jellyfish relief, hemorrhoids relief and antiseptic wipes.Albaad wipes are one-step ready for use wipes, tailored to meet our customers’ special needs and requirements. They are made with soft fabrics and impregnated with gentle yet effective liquids. The wipes are produced and tested according to stringent standards and inspected by strict quality assurance procedures.

GoalObjectives: Seeking disinfection liquid customers who wish to find a wipe expert partner to expand their line with wipes in Europe.

Seeking Private Label manufacturing opportunities for Healthcare distributors in the EU and worldwide.

Target businesses: Institutional distributors, disinfection brands and consumer healthcare brands

Target Countries: EU, worldwide

Category:

Disposables andImplantable

General Health

Industrial OEM

Infection Controland InfectiousDiseases

Company Status:

Initial Revenues

www.albaad.comAlbaad

Page 16: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

16

Schedule a Meeting at

Category:

Services

Company Status:

Revenue Growth

Company at a GlanceThe Arazy Group expertise is regulatory affairs and quality assurance for the medical device industry. Arazy Group offers medical device registration services in more than 53 countries and have gained market clearance for medical devices and IVDs in North and South America, most European countries, various Asian markets, MENA, Africa and Australia. We implement advance global regulatory products that enable our client to overcome the traditional; multiple-country regulatory compliance that is currently achieved through multiple-submission processes.For more than 16 years, our professional consultants have utilized validation, verification and regulation processes on a diverse portfolio of medical devices,and are responsible for thousands of successful registrations globally. Our customized solutions accommodate all stages of medical device’s life cycle and our adaptable services fit any application and any size organization. We Expedite Success of Safe Medical Devices.

Technology and Product(s)GlobaR™ – One World Process™Traditionally, multiple-country regulatory compliance is achieved through multiple-submission processes. The common practice is fragmented, inefficient, costly and time consuming.GlobaR™ regulatory intelligence system generates unique Global Master Regulatory File for any medical device called a GlobaR™ dossier. The following registration process is quick and efficient since this single file complies with international harmonized standards, local standards and manufacturing quality management system, creating one universal dossier which shows your device is safe and effective. Whether you are seeking enter your device into one market or multiple markets, we have the solution Our experts are often outsourced for quality and regulatory (QA/RA) positions to design and implement regulatory strategy for some of the most advanced and complex devices. Our past experiences comprise of successful registrations of various medical device categories such as, Drug Delivery, Imaging and Navigation systems, Diagnostic Software Energy emitting technology, Therapeutic Devices, Combination Devices, Active and Passive Implants, Diabetic Products, IVDs, Surgical Disposables, Dental Implants and Dental Lab Products.

GoalObjectives: Increase client base and locating local agent in additional countries.

Target businesses: Medical device manufactureres, regulatory affairs consultants and R&D companies

Target Countries: Worldwide

www.arazygroup.comArazy Group

Page 17: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

17

Schedule a Meeting at

Category:

Medical andHospital Equipment

Infection Controland InfectiousDiseases

E.M.S

General Surgery

Company Status:

Revenue Growth

www.beind.comBeth-El Industries

Company at a GlanceBeth-El Industries is a leading developer and manufacturer of medical negative pressure isolation systems and collective NBC filtration systems.Drawing on more than 30 years of experience in the air filtration field, Beth El Industries Ltd. now offers the medical market an array of stationary and portable Isolation Chambers, Clean Rooms and stand-alone Air Filtration Systems for applications in hospitals and ground or airborne ambulances.Beth-El’s IsoArk® isolation chambers are designed to quarantine infected people and protect the outside enviroment from contagious diseases like SARS, Ebola and TB.A unique series of products was developed and are now used by International Disaster Relief organization in difficult environments worldwide.

Our main features: •Quickandeffectiveisolation•Simpleandfastassemblywithnoadditionaltools• Portable solution can be brought to the problem • Variety of sizes and custommanufacturingaccordingtoourclient’srequests•Costsonlyafractionofthepriceofapermanent stationary isolation rooms.Beth-El Zikhron Yaaqov Industries Ltd. is certified for ISO 9001:2000, AQAP-2110 and AS 9100 quality management systems and is audited regularly by external entities.

Technology and Product(s)IsoArk - portable, negative pressure chamber designed for a rapid set up of a biologically isolated environment, for a quick and effective isolation of contagious people and equipment. The system includes an airlock attached to the main chamber, an air filtration system and special features that enable to treat the patient from the outside, avoiding contamination of equipment and staff.All components of the system meet and exceed today’s standards for infection isolation.IsoArk N36-4 - portable isolation chamber for transport of a single person in biological isolation. Designed specifically for the unique requirements and confided spaces of ambulances and helicopters, this new product incorporates both Isolation Chamber and Clean Room features, cleaning both the incoming and the outgoing air. Either positive or negative air pressure can be created inside the chamber, according to the users needs. With the battery fully charged, the system can operate for up to 10 hours independently of external power source and guaranties a complete isolation of the space inside the chamber during transport.The “collapsible”, lightweight structure allows for a quick set up of the system and minimal storage requirements when not in use.

GoalObjectives:•Agentabletopromoteourproductsinthemedicalandemergencyprepardnesssectorsinhiscountry•Contactwithpotentialendcustomers.Target businesses: Government agencies in charge of emergency prepardness, hospitals, importers and distributors of medical equipment, ministry of health, ambulance and ambulance equipment companies, airports. Target Countries: Worldwide

Page 18: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

18

Schedule a Meeting at

Category:

Diagnostics

Cardiovascular andPeripheral Vascular

Company Status:

Initial Revenues

www.bspmedical.comBSP Biological Signal Processing

Company at a GlanceFounded in 2000, BSP Biological Signal Processing Ltd. is a medical device company with corporate offices in Tel Aviv, Israel and a US subsidiary – BSP Inc. in Boston, MA. BSP is publicly traded on the Tel Aviv Stock Exchange since 2006 (TASE:BSP).BSP develops and commercializes a new generation of systems for non invasive diagnosis and monitoring of Coronary Artery Disease (CAD), based on advanced signal processing of the ECG signal which integrates the Company’s unique, patented, HyperQ technology.

Technology and Product(s)BSP has pioneered the clinical implementation of high-frequency ECG and has developed it into a fast, accurate, low-cost, simple to operate and non-radiating technology for detecting CAD with greater clinical value than the current standard ECG. The company’s proprietary HyperQ™ technology extracts and analyses the high-frequency components of the ECG and provides a unique diagnostic index. Thousands of patients have been tested with the HyperQ system to date, demonstrating consistently that HyperQ is far superior to conventional ECG both in sensitivity and specificity, with the potential to save up to 50% of the unnecessary radioactive imaging procedures, while improving the standard of care. BSP’s Intellectual Property portfolio is backed by four granted patents and 14 filed applications in different stages.HyperQ EX-300: The world’s first advanced system incorporating conventional stress ECG and the revolutionary highly accurate HyperQ CAD diagnosis in a single, small footprint unit. This system is FDA (510k) cleared and CE marked.HyperQ AD-100: Seamlessly integrating the highly accurate HyperQ CAD diagnosis into the existing workflow, HyperQ AD-100 is an “add-on” to standard stress ECG systems, enhancing conventional ECG results. This system is FDA (510k) cleared and CE marked.

GoalObjectives: The Company’s primary strategic objectives include establishing HyperQ as the first line modality for monitoring and diagnosis of CAD in cardiology clinics, ambulatory and hospital settings and attaining reimbursement code and premium coverage over competitors for the HyperQ diagnostic modality in the US. Growth in market penetration and market share will be achieved through a combination of business partnerships with equipment and healthcare service providers, and by the establishment of a global marketing and sales presence.

Target businesses: Distributors specializing in cardiovascular diagnostic devices, leading manufacturers in the field of cardiovascular diagnostic devices for potential business partnerships, leading health service providers.

Target Countries: Worldwide

Page 19: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

19

Schedule a Meeting at

Category:

Monitoring

Cardiovascular andPeripheral Vascular

Diagnostics

General Health

Aesthetics andDermatology

Company Status:

Initial Revenues

www.cnoga.comCnoga Medical

Company at a GlanceCnoga Medical is an innovative developer of easy-to-use, touch free and non-invasive medical devices.

It is Cnoga’s belief that the time is soon approaching when most blood tests will be conducted by the patients themselves, in the comfort of their own homes, and with a simple non-invasive device.

Technology and Product(s)CNOGA Medical’s technology provides a new patent pending and state of the art solution for the non-invasive / touch free methods of measuring physiological parameters.

CNOGA’s technology is based on real-time tissue photography, tissue image color is being processed in real-time, providing the temporarily color distribution, using dynamic range of at least 36 color-depth representing over 6.8^10 color combination then by using sophisticated mathematical algorithm, the vast amount of information is being computed and analyzed for detecting the correlation between temporarily color pigmentation and a specific bio or physiological parameter.

Products:The TensorTip VSM – Pulse rate, Blood Pressure and SpO2 monitoring deviceThe Hemoximeter – Hemoglobin, Pulse rate, SpO2 monitoring deviceThe Glucometer – Blood glucose, non-invasive, monitoring device

GoalObjectives: Meet potential business partners and distributors as well as potential customers

Target businesses: Medical Device Distributors, hospitals and medical insurance companies

Target Countries: Global

Page 20: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

20

Schedule a Meeting at

Category:

Medical andHospital Equipment

Aesthetics andDermatology

General Health

Neurology andDegenerativeDiseases

Company Status:

Initial Revenues

www.coolsense.netCoolSense Medical

Company at a GlanceCOOLSENSE Medical Ltd. is a subsidiary of the M.D. Clinic Group based in Tel-Aviv, Israel; an established and prestigious medical health center whose specialty in non-surgical aesthetic procedures serve an extensive network of cosmetic treatment clinics. CoolSense Medical Ltd. was responsible for the R&D that preceded the manufacture of the innovative hand-held CoolSense™ pain numbing applicator. CoolSense’s successfully implemented concept offers medical personnel, aestheticians and the general public a revolutionary but simply operated instrument that eliminates the pain and discomfort of injection procedures. CoolSense™ Pain Numbing Applicator which received CE approval, FDA Certification as well as the Israeli “Certificate of Free Sale” is in use worldwide. CoolSense Medical intends launching MIGROCALM™ during Medica 2011. MIGROCALM™ is an innovative self-regulated therapeutic device for the emergency relief of severe migraine type head pain.

Technology and Product(s)The innovative CoolSense™ device, when applied to the skin immediately anesthetizes the site of injection with no after effects. The CoolSense Pain-Free Injection Applicator has been accepted as an indispensable instrument for health care personnel when performing medical or cosmetic skin invasive procedures. The CoolSense™ Applicator is also an invaluable tool that greatly improves the quality of life for individuals who are obliged to undergo injection procedures on a daily basis. CoolSense™ acts within 3-5 seconds to do away with the stress and fear that is associated with receiving injections, the most common health-care procedure worldwide.The MIGROCALM™ - An innovative self-regulated therapeutic device for the emergency relief of severe migraine type head pain. MIGROCALM™ has been designed for personal use in the home; offers drug-free, noninvasive and highly effective relief of severe migraine associated head pain.

GoalObjectives: Finding potential distributors for main European and Latin American countries

Target businesses: Distributors

Target Countries: Germany, France, Switzerland, UK, Latin America.

Page 21: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

21

Schedule a Meeting at

Category:

Medical andHospital Equipment

Respiratory andPulmonary

Company Status:

Clinical Trials

Discover Medical Devices

Company at a GlanceDiscover Medical Devices (DMD) has developed a revolutionary new Continuous Positive Air Pressure (CPAP) interface – the SomnuSeal masks line for Obstructive Sleep Apnea (OSA). Patients quickly adjust to the comfortable self-adaptable oral mask, solving the market’s greatest problem – how to increase the low compliance rates for CPAP treatments. This is an unmet need and DMD is the first to successfully address it. DMD makes it possible for the market, with its well established distribution, sales and reimbursement infrastructure, to grow from $3B and reach its full $30B potential.

SomnuSeal benefit for a strategic partner: • Willincreaseworldwidemarketby>3b$/yr• Answersanunmetneed(nocurrentcompetition)• Perceived“Innovative”and“Leadingedge”technology.• Willprovideamassivecompetitiveadvantageand‘lockingin’ofthenewlyacquired

market share of non compliant patients

Technology and Product(s)Approximately 5% of the population requires CPAP treatment for OSA, including more than 15 million people in the US and 350 million more around the world. DMD designed the revolutionary SomnuSeal masks from the ground up to solve the most serious problem in the OSA market today – despite the dangers of OSA, roughly 50% of diagnosed patients stop their CPAP treatment because they cannot sleep comfortably with the cumbersome masks that exist today. In contrast to available traditional masks, DMD’s solution (the SomnuSeal masks line) uses the natural oral cavity anatomy to create the seal required for effective CPAP treatment. This innovative development makes it very easy for patients to quickly adjust to the DMD small self-adaptable mask, which does not occupy external facial structures, does not contact sensitive internal oral structures, and does not create any of the side effects that are typical of existing devices.The SomnuSeal is the first and only mask that addresses the non compliant patient market segment successfully.

GoalObjectives: To establish distribution network

Target businesses: Distributors that are experienced and successful in sales to sleep apnea patients

Target Countries: Worldwide

www.discovermedical.com

Page 22: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

22

Schedule a Meeting at

Category:

Diagnostics

Robotics

LaboratoryEquipment

Company Status:

Revenue Growth

www.dyn.co.ilDYN Diagnostics

Company at a GlanceDyn Diagnostics Inc. is engaged in marketing, sales and support scientific and engineering field tests of body fluids IVD - (In Vitro Diagnostics) and in research laboratories (Applied Science).Dyn Diagnostics was founded in 1990 and since its inception some twenty years ago, is the exclusive representative in Israel of Roche Diagnostics, which is the world’s largest and leading company in the IVD field.The company completes it’s product line in which Roche is inactive by representing leading companies such as - (Horiba ABX, Grifols, Aesku.Diagnostics etc.), wide product range allows the perfect offering and comprehensive solutions in the field of diagnostics.Dyn Diagnostics is working to implement technologies, innovative processes and advanced testing of human body fluids in the various performance sites. The company’s activity is based on a foundation of over a hundred employees with a broad education and skills such as - biological sciences and engineering, information systems, distribution and logistics as well as on experience and knowledge accumulated in the last twenty years.

Technology and Product(s)DYN DS Decapper, Sorter and ArchiverThe DYN DS is a primary sample decapper/sorter and archiver that is built to efficiencies. The DYN DS decaps different types of closures on standard primary sample tube sizes and automatically sorts up to 1,000 tubes per hour. Tubes are sorted for any laboratory analyzer or target and then finally for archiving.

Genotype DNA marker kits We at Dyn market commercial vegetable DNA marker tests.We have been marketing DNA marker test kits, and services locally, for more than 3 years, to all major local vegetable breeders\seed companies.Our customers use our test either as a DNA marker selection tool to assist breeders, or as a post control tool to confirm seed production purity.

GoalObjectives:• EstablishJointVentures;• FindBusinessPartnerthatwouldliketorepresentourproductsinvariouscountries;• Establishbusinessreletaionswith internationalMedicalDevicecompanies lookingto

enter the Israeli market.

Target businesses: Distributors

Target Countries: Worldwide

Page 23: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

23

Schedule a Meeting at

Category:

Medical andHospital Equipment

Monitoring

General Health

Company Status:

Initial Revenues

www.earlysense.com

Company at a GlanceEarlySense is bringing to market an innovative contact-free patient supervision technology.EarlySense’s continuous early sensing capabilities and patient management tools empower the medical staff in the unmonitored units to improve clinical outcomes and reduce pressure ulcers and patient falls by measuring key parameters through a sensor places underneath the patient’s mattress.The continuous patient supervision device that follows and documents patients’ vital signs and movement, allows nursing staff to proactively reduce adverse events.EarlySense’s system bridges the critical time gap between patient deterioration and clinician intervention. In light of the JointCommission’s 2009 Patient SafetyGoals forhealthcare organizations, EarlySense’s technology offers a timely solution for detecting changes in a patient’s condition, while also assisting nurses to focus on the patients who need their immediate attention.

Technology and Product(s)EarlySense’s technology has three main components: 1. a unique single plate sensing unit2. a bedside monitor that processes and displays the measured data; and -3. a Central Display Station that enables complete coverage of a unit wide set of monitors

at the nurses’ station and the different alerts are delivered to the nurses’ handheld devices.

The system’s built-in management tools include a wide range of reports on the status of patients at all times and can be printed for documentation and clinician analysis. Once placed under a bed mattress, the sensing unit immediately self-activates when sensing the patient in bed. The system is FDA cleared and CE approved and has been shown to improve clinical outcomes in general care units.

GoalObjectives: To be a market leader in the Medical Supervision Field

Target businesses: Sales in USA, Major Clniical study in Harvard/leading university

Target Countries: US, Europe

EarlySense

Page 24: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

24

Schedule a Meeting at

Category:

Diagnostics

Monitoring

Telemedicine andHealthcare IT

Cardiovascular andPeripheral Vascular

General Health

Company Status:

Initial Revenues

Company at a GlanceElitar Medical is a medical device company founded in Israel in 2005. The company’s mission is to offer a full range of non-invasive, multi-parameter patient monitoring devices and health management software tools to the full satisfaction of its customers and end-users.Elitar stations can be used for preventive screening for emergency room of national hospitals. Elitar develops and manufactures distinct and innovative products hardware and software.The company’s unique approach encourages the adoption of a preventative medicine and healthy lifestyle by simplifying the diagnosis and implementation processes by health stations, both of the individual and for the accompanying professionals.

Technology and Product(s)Elitar provides: health station, specially designed to meet the needs of individuals and organizations that either wish to cut down their costs (e.g., hospitals and retirement homes), to increase their profits (e.g., pharmacy chains and gyms), or to improve their health and nutrition management. The health station provide gold standard measurement some or all of the following vital signs: height, weight, BMI (Body Mass Index), RMR (Resting Metabolic Rate),hand grip strength test, body composition, blood pressure, pulse rate, electrical activity of the heart (EKG), heart rhythm regularity oxygen saturation, body temperature – all through a quick, non-invasive, single-posture process. In addition, they can be complemented by external monitoring devices. Elitar’s health station is automatically subscribed to the complementary health and weight management software BioFat and can be subscribed to Telehealth CheckUp, Elitar’s most advanced health station model, also includes video-conferencing any other external database, including electronic medical records (EMRs) and other telecommunications features, and can be also compatible with the medical magnetic or smart card.

GoalObjectives: To establish distribution network worldwide, joint-ventures with customers or distributors of diagnostic devices, health insurance companies

Target businesses: Hospitals, private clinics, medical devices distributors, health spa channels, pharmacies

Target Countries: Europe, Asia, North Africa, Middle East

Elitar Medical www.elitr.com

Page 25: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

25

Schedule a Meeting at

Category:

Wound and PainManagement

Aesthetics andDermatology

Rehabilitation

Medical andHospital Equipment

Company Status:

Revenue Growth

www.gd-energies.com

Company at a GlanceAs a company whose goal is to bring innovations in treatment, care, and quality of life to more and more people, we are proud to present you with cutting edge technology in soft Laser Therapy: B-Cure Laser is the world’s first portable soft Laser medical device WITH THE HEALING POWER OF A CLINIC.B-CURE Laser is recommended by the best leading specialists and is used widely in Israel by the leading pain clinics, wound healing clinics, and orthopedic departments in the followinghospitals:Hadassah-Jerusalem,Sourasky,Rambam,andShiba(TelHashomer).It is also used in physiotherapy clinics of Israeli Defense Forces, leading sports clubs, and the best sportsmen in Israel, as well as by thousands of individuals for self-treatment at home.OnJanuary2010B-CureLaserreceivedtheEuropeanCE0120approvalfor16indicationsand is presently being exported to some European countries. CE 0120 approved indications for the B-Cure Laser are: knee pain, neck pain, pain in lower and upper back, sports injuries, muscle pain, arthritis, fibromyalgia, tennis elbow, achilles tendonitis, carpal tunnel syndrome, inflammation, wound healing, burns, fresh surgical scars, post-pregnancy stretch marks, acne, herpes simplex, dental medicine, acupuncture.

Technology and Product(s)B-Cure Laser - LLLT 808 - Low Level Laser TreatmentThe soft-laser affects the skin’s surface and simultaneously penetrates the skin without heating or hurting the skin. Soft laser treatment biostimulates the body’s natural healing mechanism on a cellular and systemic level. The result: every kind of cell receives the energy required for activating and enabling optimal functioning in the body, thus allowing it to “self-heal” and naturally overcome specific problems. B-CURE LASER - an international breakthrough in soft-laser therapy for professional and personal treatment of the above mentioned indications. Thanks to an exclusive, patent-pending development, we have created an exceptional combination: the power and full coherence of a clinic’s soft-laser device over a large area of 4.5 cm², with a portable, rechargeable, safe and easy-to-use device – all at a reasonable price.The result: a perfect combination of the most effective therapy with the ability to provide immediate and continuous treatments, thus enabling high quality and fast recovery in shorter individual treatment times, and with less total healing time.OUR INNOVATION FOR MEDICA 2011: B-CURE LASER PROFESSIONAL.

GoalObjectives: Distribution

Target businesses: End-users for self-treatments at home, Pharmacies-a unique business model, Clinics, Hospitals, Sports teams, Athletes, Security forces, Home care, Nursing homes.

Target Countries: EU, USA, South America, Australia

Erika Carmel Ltd.

Page 26: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

26

Schedule a Meeting at

Category:

Disposables andImplantable

Intensive Care

General Surgery

Respiratory andPulmonary

E.M.S

Medical andHospital Equipment

Company Status:

Revenue Growth

www.etview.com

Company at a GlanceETView is a commercial stage, publicly traded medical device company focused on combining airway management with continuous direct visualization for multiple thoracic surgical procedures as well as long term ventilator dependent patients. ETView manufactures the Tracheoscopic Ventilation Tube (TVT), an endotracheal tube fitted with a camera and a light source. TVT combines high-flow ventilation, airway management and continuous video monitoring to overcome current limitations and associated adverse surgical procedure events during lung isolation surgeries as well as managing and limiting potential surgical injuries resulting from percutaneous tracheotomy and anticipated difficult intubations.The TVT is also sold as a trainer, and is the ideal device for teaching and refreshing intubation skills to medical students, anesthesiology residents and emergency personnel.

Technology and Product(s)ETView’s patented single-use tracheoscopic ventilation tube (TVT) incorporates a video camera and light sourc embedded in the tip of an endotracheal tube. The images from the TVT can be viewed on ETView’s dedicated monitors, or on other hospital medical monitors.With a camera at this critical location, medical personnel can effectively monitor surgical procedures such as the placement of endo-bronchial blockers in lung isolation procedures and the performance of percutaneous tracheotomy in long term ventilated patients in the ICU as well as constantly monitor the endotracheal tube tip’s position in such patient groups.The TVT is indicated for use in the OR and ICU.

GoalObjectives: To find distributors which will sell the TVT in their respective markets

Target businesses: Distributors

Target Countries: Worldwide

ETView

Page 27: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

27

Schedule a Meeting at

Category:

Disposables andImplantable

E.M.S

Company Status:

Revenue Growth

www.firstcareproducts.com

Company at a GlanceFirst Care Products specializes in the development and marketing of new products for pre-hospital emergency medical situations. The company’s mission is to provide intelligent, innovative, effective and simple to use products which assist in life-saving, improve the treatment provided and yield significant savings in time and resources.

Save One Life, Save A WorldActive in medical R&D, the company develops beneficial solutions for pre-hospital medical emergencies. First Care Products provides medics, first responders and the injured themselves with easy and quick to use, effective products for the control of hemmorhage resulting from trauma that save lives and greatly boost the treatment provided whether on the battlefield, homefront or accident scene. The company brings its years of comprehensive R&D and field experience to create products that when every second counts make the difference between life and tragedy.

Technology and Product(s)The Emergency BandageFirst Care Products’ first and flagship product, The Emergency Bandage in all its versions has been designated as the “STANDARD” Personal Field Dressing by numerous major, quality military organizations and is being utilized by Special Forces and military medical corps worldwide. The Emergency Bandage is combat and clinically proven, being relied upon as an integral and vital component in the treatment of hemorrhage and trauma related injuries.

Beyond Military UseIn addition to militaries around the world, First Care Products supplies its innovative bandages to governmental and private emergency medical services, Fire Rescue, Police and Prison Authorities, First-Aid and Survival Academies, and suppliers of first-aid equipment to the general public.

Worldwide Patent and ApprovalsFirst Care Products’ bandages are Patented worldwide, FDA and CE Approved, with Health Ministry Approvals in each territory, NATO Reference Numbers, and NSN’s in the USA. First Care Products manufactures all its products according to the highest International Standards including ISO 13485.

GoalObjectives: Strategic Alliances

Target businesses:

Target Countries: Worldwide

First Care Products

Page 28: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

28

Schedule a Meeting at

Category:

Medical andHospital Equipment

Rehabilitation

Intensive Care

Respiratory andPulmonary

E.M.S

Company Status:

Revenue Growth

www.flight-medical.com

Company at a GlanceFlight Medical is a leading manufacturer of high end PORTABLE VENTILATORS. The company developed and manufacture the legendary HT50 and sold over 15,000 worldwide. Flight Medical has recently launched the Flight 60 ventilator deploying its proprietary leading edge technology.

Technology and Product(s)The Flight 60 follows the success of more than 15,000 HT50 ventilators deployed worldwide. Flight 60 is an all-purpose ventilator designed to address the growing need for ventilation in Home Care, Long Term Care, Emergency, Transport, Hospital and Sub-Acute. The newly introduced Flight 60 Ventilator is offering a lot more – • ACompleteVentilationSuite• AllPressureandVolumeventilationmodes• Actualflowmeasurements(Vti,Vte)• EmbeddedFiO2sensor• Singlelimbandduallimbmode• Autonomous• 12hoursbatterylifefurtherextendedbyhotswap• Lowflowandhighpressureoxygensourceconnection• Lightweight,portableandrobust• IntuitiveandEasytoUse• 7”coloredtouchscreen• Allventilationparametersonasinglescreen• Enhancedgraphicaldisplay• Cutting-EdgeDualMicroPistonTechnology• Topclinicalperformance• LowpowerandO2consumption• Lowheatgeneration• Lowcostofownership

GoalObjectives: Establish global distribution network.

Target businesses: Distributors of medical devices to Home Care, Hospitals and Long Term Care markets

Target Countries: Asia, Americas, Europe, India

Flight Medical Innovations

Page 29: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

29

Schedule a Meeting at

Category:

Monitoring

Infection Controland InfectiousDiseases

Medical andHospital Equipment

Company Status:

Revenue Growth

Company at a GlanceHyginex, founded in 2008, brings a new era to hospital hygiene and infection control. Hyginex’s technology combines an advanced network of sensors, and an online server to process and display hand hygiene information. The Hyginex breakthrough enables for the first time real monitoring, management and control of the hospital staff hand hygiene protocol compliance and quality.With “You Can Control Only What You Can Measure” as its motto Hyginex’s product enables hospital management to receive simple and detailed reports that describe the hand hygiene compliance and the washing act.

Technology and Product(s)The Hyginex system is a complete wireless hand hygiene monitoring system for healthcare staff – monitoring whether they clean their hands when needed and if they do so according to the protocol.The system creates detailed reports from the collected data and provides a simple and flexible user interface for understanding current status and trends of the hand hygiene in the hospital.Constant monitoring increases hand-hygiene compliance with almost no management effort and minimal educational overhead. On-line Real-time alert system enables management to be updated immediately on any deviation from the hospital defined hand hygiene policy. Personal alerting enables workers to receive immediate feedback that enables them to greatly improve their hand hygiene compliance and quality.

GoalObjectives: System Marketing, Establishment of Distribution partnerships

Target businesses: Distributors

Target Countries: Worldwide

Hyginex www.hyginex.com

Page 30: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

30

Schedule a Meeting at

Category:

Diagnostics

Medical andHospital Equipment

Monitoring

Telemedicine andHealthcare IT

Cardiovascular andPeripheral Vascular

Respiratory andPulmonary

Company Status:

Initial Revenues

Company at a GlanceHypnoCore’s vision is to become the global leader of sleep diagnostics services, devices, and solutions for the medical and consumer markets.HypnoCore Ltd. aims to revolutionize the field of sleep diagnostics and improvement solutions utilizing web and mobile technologies, medical and consumer devices, to allow accurate and affordable access to sleep diagnostics and health improvement solutions for the consumer and medical markets.

Technology and Product(s)Following over a decade of academic research and years of R&D, HypnoCore Ltd. has developed patented, FDA and CE approved technology that analyzes the strongest and most robust signal, the electrocardiogram (ECG), in order to evaluate sleep and diagnose sleep disorders.

Based on it’s core IP, HypnoCore developed a set of products:• HC1000P: HypnoCore’s flagship product - reliable, automated diagnostic software that

relies on ECG and oximetry measurements to evaluate sleep and diagnose sleep related breathing disorders

• HC1000: Diagnostic software that analyzes ECG data to diagnose insomnia• SleepWay: Web-based system for centralized scoring and data management• SleepRate: Utilizing the latest sensor technology, internet and mobile technologies,

HypnoCore Ltd. is developing a new lineup of consumer products and services under the SleepRate brand

HypnoCore www.hypnocore.com

Page 31: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

31

Schedule a Meeting at

Category:

Disposables andImplantable

Medical andHospital Equipment

General Surgery

Company status:

Revenue growth

www.intromedix.comIntromedix

Company at a glanceIntromedix is an Israeli manufacturer of premium quality, cost- effective, generic, disposable surgical equipment.

Intromedix has been certified ISO 13485 and has applied a Quality Management System according to 93/42/EEC. Certification was given by the German Notified Body Medcert.

Technology andProduct(s)*• Surgicalsutures-absorbableandnonabsorbable• Surgicalstaplers• Skinstaplers• SurgicalMesh

GoalObjectives: Establish global partnership channels for the distribution of our products

Target businesses: Distributors

Target countries: All

*All products are certified

Page 32: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

32

Schedule a Meeting at

Category:

Diagnostics

Cardiovascular andPeripheral Vascular

General Health

Neurology andDegenerativeDiseases

Respiratory andPulmonary

Company Status:

Revenue Growth

www.itamar-medical.comItamar Medical

Company at a GlanceItamar Medical Ltd., is a public traded (TASE: ITMR) bio-medical technology company. Itamar develops and markets noninvasive diagnostic medical equipment based on proprietary PAT™ (Peripheral Arterial Tone) Signal. The PAT™ Signal serves as a noninvasive window to the Cardiovascular and Autonomic Nervous Systems. The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip by specialized noninvasive probes. Itamar’s FDA cleared and CE marked PAT-based products are:• Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial

function assessment – the precursor (earliest clinically detectable stage) of cardiovascular disease.

• Watch-PAT200: ambulatory diagnosis of sleep related breathing disorders and sleep staging (Wake/REM/Deep sleep/light sleep stages).

Both devices are used in preeminent clinical institutions, research centers and Pharmaceutical clinical phase studies in over 40 countries which have yielded nearly 300 publications.

Technology and Product(s)Sleep testing - at homeConsidered “best in class”, WatchPAT (FDA cleared and CE marked) is a wrist mounted device for at-home testing of sleep apneas and sleep staging (REM/Deep Sleep/Light Sleep/Wake stages). WatchPAT also measures snoring and body position and provides a perfect combination of natural sleep at home with sleep-lab level data.WatchPAT works without the multiple cables and electrodes needed by other technologies which provide in-depth analysis of sleep, so it has an incredibly low failure rate. Yet the physician gets a comprehensive report with all the clinical parameters needed for patient treatment and monitoring. While the data is calculated automatically by the WatchPAT’s software, the physician can easily edit the data too.

Noninvasive cardiovascular risk assessmentAtherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field of endothelial function assessment, EndoPAT (FDA cleared and CE marked) is used in pre-eminent clinical institutions, research centers and Pharma studies. The noninvasive EndoPAT has been validated by nearly 100 publications and abstracts and provides clinicians with reliable and reproducible results in an office-based, 15 minute test.

GoalObjectives: Establish wide distribution network in Europe

Target businesses: Distribution

Target Countries: Brazil, Germany, UK, Spain, France, China, other

Page 33: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

33

Schedule a Meeting at

Category:

Diagnostics

Neurology andDegenerativeDiseases

Wound and PainManagement

Company Status

Revenue Growth

www.medoc-web.comMedoc

Company at a Glance Medoc is a leading manufacturer of neuro-diagnostic medical systems and advanced thermal stimulators for the assessment of chronic pain. Medoc's products evaluate the small and large peripheral sensory nerve fibers (A-delta and C fibers), constituting the "Pain Pathway". In 2006, Medoc established the "Medoc Israel" division. This division represents companies world-wide, promoting and distributing their advanced medical solutions to the Israeli market. Medoc Ltd. has developed several strategic collaborations with leading international suppliers from the USA and Europe including Boston Scientific for treating severe and chronic pain patients by implanting advanced spinal cord stimulation (SCS) device, Neurotherm for treatment of local pain by applying Radio Frequency (RF) directly to the pain source, Epimed for nerve block solutions and catheters and HydroCision for minimal invasive disc-ectomy.

Technology and Product(s)The PATHWAY Pain and Sensory Evaluation System offers new applications for advanced pain research and fMRI. The PATHWAY model CHEPS (Contact Heat-Evoked Potential Stimulator) marks a breakthrough in the field of pain-evoked potential, allowing objective assessment of evoked pain. The PATHWAY model ATS (Advanced Thermal Stimulator) and PATHWAY model CHEPS are currently used in fMRI studies and in advanced pain research. The TSA-II Thermal Sensory Analyzer is used in QST (Quantitative Sensory Testing) to clinically evaluate small nerve fibers (A-delta and C fibers). The VSA-3000 Vibratory Sensory Analyzer is used in the assessment of large peripheral nerve fibers (A-beta). The recently launched Computerized Algometer is a new software-based system, providing real-time visual and auditory feedback to control and monitor applied pressure rates.Medoc will launch a series of clinical devices in the coming year to 4 years.Medoc is also interested in expanding its scope of products in the Israeli market by signing partnership agreements with promising medical device companies offering breakthrough technology and innovative products.

GoalObjectives: Looking for representatives / distributors. Medoc is curretnly in the process of penetrating the clinical market, and seeking potential collaborations with international companies which are active in the clinical field. Medoc is also interested in expanding its scope of products (for the Israeli market only) and in signing exclusive distribution agreements with promising medical device companies offering breakthrough technology and innovative products.

Target businesses: Distributors; Medical devices companies offering breakthrough technologies; Distributing channels for the clinical field.

Target Countries: Optional

Page 34: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

34

Schedule a Meeting at

Category:

Disposables andImplantable

Urology

General Health

Infection Controland InfectiousDiseases

Company Status:

Revenue Growth

www.mizramedical.comMizra Medical

Company at a GlanceMizra Medical Ltd. developed out of a family business, Mizra Latex Products founded by Mr. Zeev Mizra in 1955. The company was incorporated as Mizra Medical Ltd in 2002 and the company has grown to be the leading producer of latex disposable products in Israel. Mizra carries a complete line of continence care products and distributes specialized products that provide solutions to the challenges faced by the elderly, disabled, and others with special needs.

Technology and Product(s)Mizra Medical carries an extensive line of continence care products and distributes specialized products that provide solutions to the challenges faced by the elderly, disabled, and others with special needs.

GoalObjectives: Distribution, Alliances

Target businesses: Distributors, Hospitals, Pharmacies

Target Countries: Eastern Europe, USA, Canada, South America

Page 35: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

35

Schedule a Meeting at

Category:

Medical andHospital Equipment

Robotics

Rehabilitation

Neurology andDegenerativeDiseases

General Health

Company Status:

Revenue Growth

www.motorika.comMotorika

Company at a GlanceMotorika is a leader in manufacturing robot-assisted solutions to meet the therapeutic needs of patients suffering from a variety of neurological conditions, including stroke, traumatic brain injury, spinal cord injury, as well as orthopedic and post-surgery dysfunction.Motorika's products include upper and lower extremities function, providing better rehabilitation results through a combination of wide variation and intense repetition.

Technology and Product(s)ReoGo is the world’s most advanced robotic system for upper limb therapy, designed to facilitate three-dimensional repetitive arm movements through the use of an advanced, fully motorized robotic arm. The system is suited for a wide variety of patients in all stages of stroke recovery.ReoAmbulator is a high-end robotic gait training device that integrates Body Weight-Support Treadmill Training (BWSTT) with advanced robotics to help rehabilitate patients who experience problems with ambulation, balance, coordination, posture or stamina.

GoalObjectives: Generate interest from doctors and physiotherapists

Target businesses: Hospitals, rehabilitation clinics

Target Countries: Worldwide

Page 36: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

36

Schedule a Meeting at

Category:

Urology

Wound and PainManagement

Infection Controland InfectiousDiseases

Medical andHospital Equipment

Company Status:

Initial Revenues

www.nanovibronix.comNanoVibronix

Company at a GlanceNanoVibronix develops innovative medical devices based on its proprietary therapeutic acoustic technology.

The company two main product lines are for catheter related complications and for treatment of wounds, soft tissue and pain in a range of clinical applications.

Technology and Product(s)UroShield™ - prevents biofilm formation on catheters, thereby decreasing risk for urinary tract infection, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

PainShield™ - accelerate healing of soft tissue, non-union of fractures and relief of pain.

WoundShield™ - accelarates wound healing.

GoalObjectives: Expand distribution network

Target businesses: Distributors to hospitals, clinics, home-care

Target Countries: Germany, France, Italy, UK, Spain, Scandinavian countries, US and Asia

Page 37: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

37

Schedule a Meeting at

Category:

Disposables andImplantable

General Health

Company Status:

Revenue Growth

www.navagroup.co.ilNava Group

Company at a GlanceWe at NAVA GROUP LTD. are in the protective healthcare business since 1970. NavaGroup is among the market leaders in the top grade of quality for absorbent products, specializing in adult incontinence care. Our main products are adult diapers and bed pads. Our manufacturing plant is located in Hatzor Haglilit, Israel, and we maintain large warehouse inventories for immediate shipment via our distribution channels.NAVA GROUP LTD is a private label manufactory. We support our customers on marketing and consulting. We offer wide range of adults' diapers according to customers' specifications.

Our products are successfully sold in European and US markets, including TEVA, and are based on experience of thousands of healthcare providers from around the world. We provide the highest quality in a modern and unique technology.

Our MISSION is to offer our customers the best value for the money they spend as well as the assurance that they will provide their clients with the best level of comfort and security.

Technology and Product(s)• Chlorine-free• Hypoallergenic• Latexfree• Fragrancefree,neutralizedodortechnology• HighestqualitySAP• Supervisedcontrolledforestryforourfluffpulp• Higherabsorbency=usinglessdiapers• ISO9001qualitymanagement

GoalObjectives: Find new private label clients

Target businesses: Distributors, hospitals, old-age homes, pharmacies

Target Countries: Worldwide

Page 38: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

38

Schedule a Meeting at

Category:

Disposables andImplantable

Industrial OEM

General Health

Infection Controland InfectiousDiseases

Company Status:

Revenue Growth

Noam Urim Enterprises www.noam-urim.com

Company at a GlanceNoam Urim Enterprises Ltd. is one of the largest non-woven needle punch producers in the Middle East. Established in 1967, it supplies various fabrics/substrates for medicaluse, including soaped sponge/gloves, antibacterial cleaning cloth, white needle punch for personal care and cloth for cosmetic applications. Noam Urim supplies rolled fabrics that serve as raw material. Customers include wet wipes producers and converters for many other spheres: cosmetics, medical (hospitals, hotels etc.) and cleaning products.We can define the perfect fiber blend for any application in all packaging phases – from big mother rolls to bulk packaging and private label. We produce tailor-made articles and runs for fast development. The company is IS0 9001:2000 certified, assuring the highest standard of quality for all products, which are exported worldwide.

Technology and Product(s) Soaped sponge – gentle soap especially designed for personal healthcare in hospitals and other health centers. When the sponge makes contact with water, the cleaning agent is activated. The wipe substrate can be impregnated with almost any soap or detergent – perfect for practically any purpose. The growing demand for wet wipes and the need for constant upgrading of the product means increased demand for needle punch material for dry application. • Dryversionofsoapedsponge• Lightweight• 2in1,replacingneedforsoapandspongeseparately• Single-use• Long-lasting• Manyapplications:personalcare,petcare,generalcleaning,carcareandmore• Idealfordailyuseandsensitiveskin

Antibacterial Wipes – provide permanent built-in protection against the growth of bacteria, mold, fungi and yeast. Long-lasting antibacterial protection does not wash off. Unique treatment during production ensures wipes are non-allergenic, safe, can be used longer and are more hygienic.

Cosmetic Dots – wipes containing dots (from gentle to abrasive).

White needle punch-producedinbigmotherrollsforhygiene,>90sqm,min15cmwidth (gloves).

Goal Objectives: Distribution, alliances, customers (converters and private label)

Target businesses: Hospitals, clinics, cosmetics

Target Countries: Worldwide

Page 39: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

39

Schedule a Meeting at

Category:

Medical andHospital Equipment

General Surgery

Disposables andImplantable

Company Status:

Revenue Growth

www.hemaclear.comOHK Medical Devices

Company at a GlanceThe creators of HemaClear® saw the need for a new, different kind of tourniquet, one that would be simple, safe, sterile, and more cost-effective than any device on the market today. So they had a vision, and realized it. HemaClear® is the first and only single-use device that exsanguinates, occludes, and provides a clearer surgical field. Beginning with a sterile field allows surgeons to place the device closer to the site than ever before. Its narrower size provides a larger, dryer, and clearer surgical field, for a better view of anatomical structures. Instant, on-the-spot sterility, and greater access to the surgical site assures a safer, more successful surgical outcome. Its innovative technology not only reduces blood loss, infection, and the volume of ischemic tissue, it’s simplicity saves precious OR set-up time as much as fifteen minutes and over 100 separate steps that can add as much as $300 to every procedure. In fact, HemaClear® is so revolutionary, it represents the single greatest advance in tourniquet technology since the Esmarch bandage. HemaClear® has been proven worldwide in over 150,000 surgical cases from the OR to disaster-struck areas all around the world. (The recent earthquake in Haiti).

Technology and Product(s)HemaClear is designed to create a bloodless field for limb surgery, quickly and effectively without wasting precious time and materials. In the center of the device, a specially engineered silicone ring exerts just enough circumferential pressure as it rolls up the limb to exsanguinate completely and occlude the blood vessels - without damaging soft tissue and nerves.Factory calibrated and pre-set, HemaClear delivers uniform and reproducible results. Full range of sizes to accommodate almost every patient type, from pediatric to obese (limb circumference of 14 to 90 cm).

GoalObjectives: Develop a distribution network

Target businesses: Orthopedic surgeons

Target Countries: Germany, Belgium, Holland, Switzerland, Scandinavia

Page 40: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

40

Schedule a Meeting at

Category:

Medical andHospital Equipment

Company Status:

Revenue Growth

www.polytex.co.ilPolytex Technologies

Company at a GlancePolytex Technologies Ltd. provides advance solutions for textile management such as distribution of uniforms, garments, special wear for clean rooms, operating rooms scrubs, hotel towels, etc. The Polytex solution is based on unique, patented developments, which provides the Polytex systems great advantages in terms of speed and reliability of service, capacity and costs. Our systems are installed at various sites from factories as Intel R&D centertomedicalcenterslikeHadassaMedicalCenterinJerusalemandVald'HebroninBarcelona.

Technology and Product(s)The Polytex products are divided into textile dispensing units and textile return units for various applications. all our products are based on a patented technology, developed by Polytex. The Polytex technology allows our systems to distribute folded items. When compared to existing solutions in the world, our systems provides the best solution in terms of speed and reliability in distributing the textile items, speed in loading the items to the system, very low maintenance needs, high capacity and relatively low costs.

GoalObjectives: To find potential clients and distributors

Target businesses: Hospitals, industrial laundries, dealers and distributors of industrial machinery for laundries, dealers and distributors of hospital logistics systems

Target Countries: Worldwide

Page 41: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

41

Schedule a Meeting at

Category:

Disposables andImplantable

Cardiovascular andPeripheral Vascular

Wound and PainManagement

Infection Controland InfectiousDiseases

Company Status:

Revenue Growth

www.sb-medical.comSion Biotext Medical

Company at a GlanceSion Biotext Medical Ltd. Is a leading manufacturer of single-use skin cleansing and treatment, wound care and surgical solutions for the professional health care sector.The rich product formulations provide additional values, in the cost per unit as well as the volumes needed for each usage. Sion Biotext medical provide the products in a variety of package sizes and dispensing options, each one designed to address specific uses and needs.Our products are nurse orientated although technology is driving physician interest. We seek to reduce the cost of healing to the healthcare provider.The company’s quality system is accredited to ISO 9001, ISO 13485 and GMP regulations. The products bear the CE mark certification and F.D.A.

Technology and Product(s)Cleansing and Care Line offers a wide range of skin antisepsic products used to minimize infections caused by skin pathogens, and include:• Chlorhexidine(0.5%)andAlcoholPrepPads• P.V.PPrepPadsandSwabsticks• AlcoholPrepPadsandSwabsticks• LemonGlycerinSwabsticks• ElectrodeSkinPrepPads• AdhesiveTapeRemoverPads• SkinCoatPrepPads

Skin Care and Patient Treatment products are delivered in pharmaceutical – grade bases and serve to protect the skin and maintain optimal skin integrity, and include:• SterileLubricanJelly• FirstAidOintmentsandCreams• ZincOxide,VitaminAandDOintment• PetrolatumOintment

Wound Care Line combining the traditional bandage and the impregnating technology resulted in a new age product line:Zinc/Calamine Paste/bandages for the management of venous leg ulcers and Ice Cool Elastic Bandages, a revolutionary product designed to deliver cold and compression to the afected area for treatment of sport injuries bruises, inflamations and sprains.

Surgical Line offers complete solution in the operating theatre by providing products such as drapes, packs and staff clothing, customised procedure packs/trays.

GoalObjectives: Distribution, alliances

Target businesses: Clinics, hospitals, home care

Target Countries: Europe, US, Canada, South America, Australia

Page 42: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

42

Schedule a Meeting at

Category:

Medical andHospital Equipment

Aesthetics andDermatology

Company Status:

Revenue Growth

www.tav-tech.comTavTech

Company at a GlanceTavTech Ltd. is an innovator of state-of-the-art technology, incorporating jet aviation principles and engineering. TavTech's unique systems use only natural components - air (or medical gas) and water - accelerated to supersonic speeds to achieve the desire effect on tissue. The technology is patented and has broad application across the medical spectrum.

Aesthetic Medicine and CosmetologyTavTech's industry-leading exclusive technology brings new dimensions to Aesthetic Medicine. TavTech's JetPeel systems provide multi-functional skin rejuvenation usingnature's own elements - air, oxygen (or other medical gas) and saline solution. They are designed for skin rejuvenation, facial resurfacing, removal of age and hyperpigmentation spots, peri-oral wrinkles, facial deep cleansing (pores, comedones) and moisturizing, and for use on scars, acne, stretch marks, scalp and a variety of other applications, all painlessly. Jet-M that is perfectly positioned to meet the needs of the changing market. Jet-Mprovides non-traditional physicians, medspas, and para-medical practitioners, affordable, multi-function treatment procedures for the aesthetic market. Please visit our website www.tav-tech.com.

Technology and Product(s)Jet aviation engineering is being used by TavTech to meet the needs of the rapidlyexpanding aesthetic, skin care and wound management markets. TavTech's patented technology creates two-phase jet of micro-droplets consisting of saline solution and gas (air or medical gas) that is accelerated to velocities that reach 200m/sec., providing a versatile and precise means for performing a wide variety of skin treatments.The pressure created by the high-velocity jet stretches the skin at the point of contact, causing "barophoresis" due to pressure variance; the skin in the high- pressure zone forms a concave surface and micro-canals in the outer layer of the skin broaden as the skin stretches and new canals are created. This process facilitates hydration, cleansing and purifying of the treated area, opens access to the skin's inner layers, allowing for deeper penetration, and the introduction of vitamins, anti-aging and other solutions.

GoalObjectives: Identify partners/distributors

Target businesses: Qualified partners/distributors

Target Countries: Germany, Australia, France

Page 43: Medica 2011 catalogue

Return to Table of Content

Israel Medical Innovation2011

43

Schedule a Meeting at

Category:

Disposables andImplantable

Monitoring

Diagnostics

Urology

Intensive Care

Company Status:

Pre-Clinical

www.vasa-at.comVasa Applied Technologies

Company at a GlanceVasa Applied Technologies Ltd. is a privately-owned Israeli start-up company that developed a patent-pending technology that allows direct flow measurement of secreted body fluids and low cost devices for growing market niches – breastfeeding and Urology catheters.

Technology and Product(s)A technology for measuring pulsating low flow rates of fluids excreted and secreted from the body, based on a patent-pending probe. The probe is easily shaped and integrated in measuring units, currently implemented in measuring human milk flow and urine flow, for both hospitals and home environment:1) The first ever breastfeeding meter - a convenient and simple to operate device that

accurately measures the amount of milk a baby ingests during breastfeeding, for supporting breastfeeding.

2) Urine flowmeter - an in-line catheter flowmeter that accurately measures the urine output (flow rate and amount) of a catheterized patient.

Goal

Objectives: Production cooperation; distribution agreements for the two products.

Target businesses: Distributors, medical device manufacturers for strategic partnership

Target Countries: Worldwide

Page 44: Medica 2011 catalogue

44

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting

Contact our commercial attaches around the world at:

South Europe and Africa

Paris, France(+33.1)[email protected]

Milano, Italy(+390.2)[email protected]

Madrid, Spain(+34.91)782-9520/[email protected]

Johannesburg, South Africa(+27.11)[email protected]

Istanbul, Turkey(+90.212)[email protected]

North Europe

Brussels, Belgium(+32.2)3735-533/4/[email protected]

London, UK(+44.207)[email protected]

Berlin, Germany(+49.30) [email protected]

Hague, Netherlands(+31.70)[email protected]

Stockholm, Sweden(+46.8) [email protected]

Central and East Europe

Vienna, Austria(+43.1)[email protected]

Warsaw, Poland(48.22+)[email protected]

Bucharest, Romania(+40.21)3189-407/[email protected]

Moscow, Russia(+7.495)7972-737/[email protected]

Geneva, Switzerland(+41.22)[email protected]

Kiev, Ukraine(+380) 44-5861-552/[email protected]

Page 45: Medica 2011 catalogue

45

2011

Return to Table of Content

Israel Medical Innovation

Schedule a Meeting

Contact our commercial attaches around the world at:

North and South America

Sao Paolo, Brazil(+55.11) [email protected]

Toronto, Canada(+1.416) 6408-540/[email protected]

Mexico City, Mexico(+52.55) [email protected]

Washington, USA(+1-202) [email protected]

Chicago, USA(+1.312) [email protected]

Houston, USA(+1.713)[email protected]

Los Angeles, USA(+1.323)[email protected]

New York, USA(+1.212) [email protected]

Asia and Pacific

Sydney, Australia(+61.2) 93880-382 [email protected]

Tokyo, Japan(+81.3) [email protected]

Seoul, South Korea(+82.2)723-6121/[email protected]

Singapore(+65) [email protected]

Taipei, Taiwan (+886.2)2757-7221/[email protected]

Bangkok, Thailand(+66.2)2049-240/[email protected]

Hanoi, Vietnam(+84.43) [email protected]

India and China

Beijing, China(+86.10) [email protected]

Guangzhou, China(+86. 20) 8513-0518/[email protected]

Delhi, India(+91.11) [email protected]

Mumbai, India(+91.22) [email protected]